OTC Markets OTCPK - Delayed Quote USD
ProtoKinetix, Incorporated (PKTX)
0.0100
0.0000
(0.00%)
As of May 8 at 4:00:00 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Clarence Edward Smith | Chairman, President & CEO | -- | -- | 1964 |
| Mr. Michael Richard Guzzetta CPA | Chief Financial Officer | 60k | -- | 1958 |
ProtoKinetix, Incorporated
- Sector:
- Healthcare
- Industry: Biotechnology
Description
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.
Corporate Governance
ProtoKinetix, Incorporated’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 13, 2025 at 12:30 PM UTC - May 19, 2025 at 12:30 PM UTC
ProtoKinetix, Incorporated Earnings Date
Recent Events
Related Tickers
MYMX Mymetics Corporation
0.0003
0.00%
RVX.TO Resverlogix Corp.
0.0450
0.00%
TRVN Trevena, Inc.
1.2200
+6.09%
ACIU AC Immune SA
1.6700
+0.60%
AMLX Amylyx Pharmaceuticals, Inc.
4.5350
-0.98%
RLAY Relay Therapeutics, Inc.
2.9800
-0.67%
FGEN FibroGen, Inc.
0.3101
-2.91%
VIR Vir Biotechnology, Inc.
5.14
-4.99%
FATE Fate Therapeutics, Inc.
1.0700
+3.88%
ARVN Arvinas, Inc.
6.68
-1.98%